Broad testing, precise answers
With advanced genomic technologies, our unmatched internal database, and extensive clinical expertise, GeneDx’s industry-leading tests deliver clinically actionable results, faster.
Learn more
1 in 10 people live with a rare disease. We see a future where rare diseases are no longer rare in awareness, action, and care.
Ashley refused to accept a broad cerebral palsy diagnosis and pushed for a precise genetic diagnosis for her daughter—preventing permanent nerve damage and vision loss.
One third of CP cases have an underlying genetic cause that can be identified through exome. That can mean the difference between blindness and vision for children with CTNNB1.
Did you know that less than 10% of cerebral palsy cases are caused by birth asphyxia? Exome and genome sequencing can uncover the root cause—and potentially reveal a co-occurring condition.
New study shows that nearly 42% of diagnosed infants would have been missed under current NICU protocols.
Seamlessly integrate the power of GeneDx testing into your Epic Aura EHR.
We see a future where any genetic disorder is diagnosed quickly to prevent disease progression and ensure long and healthy lives for all.
The key? Exome and genome sequencing.
Recommended by guidelines as a first-line test. More likely to deliver a diagnosis.
The time for exome and genome is now.
Not a healthcare provider?
Learn more about testing here.
Exome sequencing
delivers 2x the diagnostic yield of chromosomal microarray (CMA) and multigene panels.1,2
Genome sequencing
is the most comprehensive genetic test available and includes mitochondrial genome sequencing.
Rapid genome sequencing
can help identify the 1 in 4 infants in the intensive care unit that likely have a genetic disorder.3
Ready to talk in more detail? Schedule a call today.
With advanced genomic technologies, our unmatched internal database, and extensive clinical expertise, GeneDx’s industry-leading tests deliver clinically actionable results, faster.
Learn moreThere’s a reason we’re the go-to lab when providers need diagnoses for children with both rare diseases and common conditions. It includes comprehensive, actionable results, unparalleled support, and a genuine dedication to putting patients first.
References: 1. Savatt JM, Myers SM. Front Pediatr. 2021 Feb 19;9:526779. doi: 10.3389/fped.2021.52679. 2. Srivastava S, Love-Nichols JA, Dies KA, et al. Genet Med. 2019 Nov;21(11):2413–2421; https://doi.org/10.1038/s41436-019-0554-6. 3. Kingsmore SF, Cakici JA, Clark MM, et al. Am J Hum Genet. 2019 Oct 3;105(4):719-733. doi: 10.1016/j.ajhg.2019.08.009.
